Literature DB >> 27180603

Assessment of antibodies against surface and outer membrane proteins of Anaplasma phagocytophilum in Lyme borreliosis and tick-borne encephalitis paediatric patients.

L Krbková1, L Homola1, A Hlaváčová1, P Mikolášek1, J Bednářová2, Z Čermáková3.   

Abstract

To examine evidence of positive antibodies against immunogenic proteins of Anaplasma phagocytophilum in patients with other tick-borne infections and to diagnose possible co-infections, 412 serum specimens were tested by immunoblotting using three specific Anaplasma antigens: surface proteins p44 and Asp62 and outer membrane protein A (OmpA). In total, 284 serum samples from children with Lyme borreliosis and 12 serum samples from children with tick-borne encephalitis were tested. Sera from patients with viral aseptic meningitis (n = 47) and from blood donors (n = 69) were used as controls. Among all serum specimens from patients with tick-borne infections submitted for this study, six samples (2·0%) showed positive IgM reactions and seven samples (2·4%) were IgG positive for A. phagocytophilum by immunoblot. Borderline reactivity was found in 30 samples (10·14%) for IgM and 36 samples (12·2%) for IgG. The difference between patients and blood donors was statistically significant for IgM (P = 0·006) and for IgG (P = 0·0007) antibodies. A statistically significant result was obtained for IgG (P = 0·02) but not for IgM between patients and children with aseptic meningitis. Immunoblot using three specific antigens provides novel information about the positivity of antibodies to A. phagocytophilum in children with other tick-borne infections. Taking into account clinical and laboratory findings of children despite antibody positivity, no case of human granulocytic anaplasmosis was demonstrated.

Entities:  

Keywords:  Anaplasma phagocytophilum; Lyme borreliosis; human granulocytic anaplasmosis; major surface proteins; outer membrane protein A; tick-borne encephalitis

Mesh:

Substances:

Year:  2016        PMID: 27180603      PMCID: PMC9150475          DOI: 10.1017/S0950268816000972

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  29 in total

1.  Seroprevalence of ehrlichiosis, Lyme borreliosis and tick-borne encephalitis infections in children and young adults in Slovenia.

Authors:  M Cizman; T Avsic-Zupanc; M Petrovec; E Ruzic-Sabljic; M Pokorn
Journal:  Wien Klin Wochenschr       Date:  2000-10-13       Impact factor: 1.704

2.  Summary of Notifiable Diseases - United States, 2011.

Authors:  Deborah A Adams; Kathleen M Gallagher; Ruth Ann Jajosky; Jeffrey Kriseman; Pearl Sharp; Willie J Anderson; Aaron E Aranas; Michelle Mayes; Michael S Wodajo; Diana H Onweh; John P Abellera
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-05       Impact factor: 17.586

3.  Serological evidence of human granulocytic ehrlichiosis in Switzerland.

Authors:  N Pusterla; R Weber; C Wolfensberger; G Schär; R Zbinden; W Fierz; J E Madigan; J S Dumler; H Lutz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

4.  Immunoserologic evidence of Human Granulocytic Ehrlichiosis in Danish patients with Lyme neuroborreliosis.

Authors:  A M Lebech; K Hansen; P Pancholi; L M Sloan; J M Magera; D H Persing
Journal:  Scand J Infect Dis       Date:  1998

5.  Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics.

Authors:  Yan Ge; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

6.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

7.  Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients.

Authors:  Eun-jeong Heo; Jin-ho Park; Ja-ryong Koo; Man-suk Park; Mi-yeoun Park; J Stephen Dumler; Joon-seok Chae
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.

Authors:  A Mygland; U Ljøstad; V Fingerle; T Rupprecht; E Schmutzhard; I Steiner
Journal:  Eur J Neurol       Date:  2009-11-23       Impact factor: 6.089

Review 9.  Human granulocytic ehrlichiosis in Europe.

Authors:  J R Blanco; J A Oteo
Journal:  Clin Microbiol Infect       Date:  2002-12       Impact factor: 8.067

10.  Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia.

Authors:  S Lotric-Furlan; M Petrovec; T A Zupanc; W L Nicholson; J W Sumner; J E Childs; F Strle
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

View more
  2 in total

1.  A multiplex serologic platform for diagnosis of tick-borne diseases.

Authors:  Rafal Tokarz; Nischay Mishra; Teresa Tagliafierro; Stephen Sameroff; Adrian Caciula; Lokendrasingh Chauhan; Jigar Patel; Eric Sullivan; Azad Gucwa; Brian Fallon; Marc Golightly; Claudia Molins; Martin Schriefer; Adriana Marques; Thomas Briese; W Ian Lipkin
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

Review 2.  Human Co-Infections between Borrelia burgdorferi s.l. and Other Ixodes-Borne Microorganisms: A Systematic Review.

Authors:  Pierre H Boyer; Cédric Lenormand; Benoît Jaulhac; Emilie Talagrand-Reboul
Journal:  Pathogens       Date:  2022-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.